Health Condition 1: F09- Unspecified mental disorder due toknown physiological condition
Conditions
Interventions
None listed
Sponsors
DR ANUSRI PRADEEP
Eligibility
Inclusion criteria
Inclusion criteria: 1. Subject of both sex of age group 3 to 12 years satisfying DSM 5 criteria for ASD and having a CARS score above 30 and ADHD T2 score above 60
Exclusion criteria
Exclusion criteria: 1. Clinically diagnosed cases of PDD (Pervasive developmental disorder) like Rett syndrome, Asperger’s syndrome, Childhood Disintegrative disorder, PDD - NOS (Pervasive developmental disorder- Not otherwise specified) 2. Clinically diagnosed cases of other developmental disorders and neurological disorders. 3. Children with recurrent respiratory tract infections, and intractable epilepsy. The exclusion is based on clinical features, history of illness along with available investigation report.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| PRIMARY: Amount of Change in the hyperactivity domain of ASD with siroutsadanam as compared to sirolepam. Timepoint: Changes in the pre and post assessment scores of CARS, ATEC, ADHD T2 in Hyperactivity in children with Autism. ASSESSMENT AFTER 4 WEEKS,8 WEEKS | — |
Secondary
| Measure | Time frame |
|---|---|
| To study the changes in the Behavioral & Social domain also the severity of Autism spectrum disorders (ASD).Timepoint: Changes in the pre & post assessment scores of CARS, ATEC, ADHD T2 in Hyperactivity in children with Autism. AFTER 4 WEEKS, 8 WEEKS. | — |
Countries
India
Contacts
Public ContactDR ANUSRI PRADEEP
GOVT AYURVEDA COLLEGE THIRUVANANTHAPURAM
Outcome results
None listed